Table 5

Sample size for each primary tumour site

Colorectal cancer500 patients (350 patients who have received NACT)
Ovarian cancer600 patients (350 undergoing interval CRS)
Appendiceal primary300 patients
Peritoneal mesothelioma100 patients
Gastric cancer100 patients

  • CRS, cytoreductive surgery; NACT, neoadjuvant chemotherapy.